2026 Private Sector Top 500 Decliners: Qilu Pharmaceutical, Tangrenshen, and Zhongda Holdings Each Slip Eight Spots

Deep News

Sep 23

The All-China Federation of Industry and Commerce released its "2026 China Private Enterprises Top 500" ranking on September 22, which tracks the nation's largest private firms by revenue.

Qilu Pharmaceutical Group Co., Ltd. now sits at 349th place, dropping eight positions from its 341st rank in the 2025 list. The company's revenue fell from 37.819 billion yuan to 37.119 billion yuan, a decrease of 700 million yuan.

Tangrenshen Group Co., Ltd. is ranked 444th this year, slipping eight spots from 436th in the previous edition. Its revenue declined by 1.149 billion yuan, coming in at 29.696 billion yuan compared to 30.845 billion yuan in the prior period.

Zhongda Holding Group Co., Ltd. has fallen to 485th place, down eight positions from 477th last year. The company's revenue dropped by 1.593 billion yuan, from 28.062 billion yuan to 26.469 billion yuan.

This ranking reflects the latest performance shifts among major private enterprises, with these three firms experiencing notable revenue contractions alongside their ranking declines.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1140519511"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140519511\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140519511?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-23 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140519511","market":"other","top_or_hot":-1,"title":"2026 Private Sector Top 500 Decliners: Qilu Pharmaceutical, Tangrenshen, and Zhongda Holdings Each Slip Eight Spots","media":"Deep News","content":"<p>The All-China Federation of Industry and Commerce released its \"2026 China Private Enterprises Top 500\" ranking on September 22, which tracks the nation's largest private firms by revenue.<br><br>Qilu Pharmaceutical Group Co., Ltd. now sits at 349th place, dropping eight positions from its 341st rank in the 2025 list. The company's revenue fell from 37.819 billion yuan to 37.119 billion yuan, a decrease of 700 million yuan.<br><br>Tangrenshen Group Co., Ltd. is ranked 444th this year, slipping eight spots from 436th in the previous edition. Its revenue declined by 1.149 billion yuan, coming in at 29.696 billion yuan compared to 30.845 billion yuan in the prior period.<br><br>Zhongda Holding Group Co., Ltd. has fallen to 485th place, down eight positions from 477th last year. The company's revenue dropped by 1.593 billion yuan, from 28.062 billion yuan to 26.469 billion yuan.<br><br>This ranking reflects the latest performance shifts among major private enterprises, with these three firms experiencing notable revenue contractions alongside their ranking declines.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2026 Private Sector Top 500 Decliners: Qilu Pharmaceutical, Tangrenshen, and Zhongda Holdings Each Slip Eight Spots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2026 Private Sector Top 500 Decliners: Qilu Pharmaceutical, Tangrenshen, and Zhongda Holdings Each Slip Eight Spots\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-09-23 10:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The All-China Federation of Industry and Commerce released its \"2026 China Private Enterprises Top 500\" ranking on September 22, which tracks the nation's largest private firms by revenue.<br><br>Qilu Pharmaceutical Group Co., Ltd. now sits at 349th place, dropping eight positions from its 341st rank in the 2025 list. The company's revenue fell from 37.819 billion yuan to 37.119 billion yuan, a decrease of 700 million yuan.<br><br>Tangrenshen Group Co., Ltd. is ranked 444th this year, slipping eight spots from 436th in the previous edition. Its revenue declined by 1.149 billion yuan, coming in at 29.696 billion yuan compared to 30.845 billion yuan in the prior period.<br><br>Zhongda Holding Group Co., Ltd. has fallen to 485th place, down eight positions from 477th last year. The company's revenue dropped by 1.593 billion yuan, from 28.062 billion yuan to 26.469 billion yuan.<br><br>This ranking reflects the latest performance shifts among major private enterprises, with these three firms experiencing notable revenue contractions alongside their ranking declines.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0070","symbol_name":"员工持股","start_time":0,"source_url":"","article_id":"1140519511","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140519511","pubTimestamp":1790129434,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"The All-China Federation of Industry and Commerce released its \"2026 China Private Enterprises Top 500\" ranking on September 22, which tracks the nation's largest private firms by revenue.Qilu...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0070":"员工持股","BK0195":"猪","BK1191":"制药","BK1574":"生物医药B类股","BK0039":"民营银行","BK0077":"质押式回购","BK0238":"农副食品","BK0201":"可转债","002567":"唐人神","01477":"欧康维视生物-B"},"translate_title":"2026年民营企业500强跌幅：齐鲁制药、唐人神、中大控股各下滑8位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01477":1,"002567":1},"content_text":"The All-China Federation of Industry and Commerce released its \"2026 China Private Enterprises Top 500\" ranking on September 22, which tracks the nation's largest private firms by revenue.Qilu Pharmaceutical Group Co., Ltd. now sits at 349th place, dropping eight positions from its 341st rank in the 2025 list. The company's revenue fell from 37.819 billion yuan to 37.119 billion yuan, a decrease of 700 million yuan.Tangrenshen Group Co., Ltd. is ranked 444th this year, slipping eight spots from 436th in the previous edition. Its revenue declined by 1.149 billion yuan, coming in at 29.696 billion yuan compared to 30.845 billion yuan in the prior period.Zhongda Holding Group Co., Ltd. has fallen to 485th place, down eight positions from 477th last year. The company's revenue dropped by 1.593 billion yuan, from 28.062 billion yuan to 26.469 billion yuan.This ranking reflects the latest performance shifts among major private enterprises, with these three firms experiencing notable revenue contractions alongside their ranking declines.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}